Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP867373.RA-r3bQ6qSwoDc9e5zpZHirwKz_0-aWOQFgkO8p9nPX-Y130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP867373.RA-r3bQ6qSwoDc9e5zpZHirwKz_0-aWOQFgkO8p9nPX-Y130_assertion type Assertion NP867373.RA-r3bQ6qSwoDc9e5zpZHirwKz_0-aWOQFgkO8p9nPX-Y130_head.
- NP867373.RA-r3bQ6qSwoDc9e5zpZHirwKz_0-aWOQFgkO8p9nPX-Y130_assertion description "[In addition, the combination of AICAr with antifolates [methotrexate (MTX) or pemetrexed] has been shown to further potentiate AMPK activation and to lead to greater cytotoxicity and growth inhibition in leukemia and other malignant cell types.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP867373.RA-r3bQ6qSwoDc9e5zpZHirwKz_0-aWOQFgkO8p9nPX-Y130_provenance.
- NP867373.RA-r3bQ6qSwoDc9e5zpZHirwKz_0-aWOQFgkO8p9nPX-Y130_assertion evidence source_evidence_literature NP867373.RA-r3bQ6qSwoDc9e5zpZHirwKz_0-aWOQFgkO8p9nPX-Y130_provenance.
- NP867373.RA-r3bQ6qSwoDc9e5zpZHirwKz_0-aWOQFgkO8p9nPX-Y130_assertion SIO_000772 21262957 NP867373.RA-r3bQ6qSwoDc9e5zpZHirwKz_0-aWOQFgkO8p9nPX-Y130_provenance.
- NP867373.RA-r3bQ6qSwoDc9e5zpZHirwKz_0-aWOQFgkO8p9nPX-Y130_assertion wasDerivedFrom befree-2016 NP867373.RA-r3bQ6qSwoDc9e5zpZHirwKz_0-aWOQFgkO8p9nPX-Y130_provenance.
- NP867373.RA-r3bQ6qSwoDc9e5zpZHirwKz_0-aWOQFgkO8p9nPX-Y130_assertion wasGeneratedBy ECO_0000203 NP867373.RA-r3bQ6qSwoDc9e5zpZHirwKz_0-aWOQFgkO8p9nPX-Y130_provenance.